150 related articles for article (PubMed ID: 1693502)
41. Increased cyclic nucleotide phosphodiesterase (PDE) and calmodulin activities in soluble fraction of Graves' thyroid: analysis of increase in Ca+2 dependence of PDE activities.
Yagura T; Nagata I; Kuma K; Uchino H
J Clin Endocrinol Metab; 1985 Jun; 60(6):1180-6. PubMed ID: 2987288
[TBL] [Abstract][Full Text] [Related]
42. Isoelectric-focusing patterns of cyclic nucleotide phosphodiesterase from rat heart.
Némoz G; Prigent AF; Pageaux JF; Pacheco H
Biochem J; 1981 Oct; 199(1):113-9. PubMed ID: 6279093
[TBL] [Abstract][Full Text] [Related]
43. Calmodulin fragments can not activate target enzymes.
Minowa O; Yazawa M; Sobue K; Ito K; Yagi K
J Biochem; 1988 Mar; 103(3):531-6. PubMed ID: 2839470
[TBL] [Abstract][Full Text] [Related]
44. Ruthenium Red inhibits the activation of pyruvate dehydrogenase caused by positive inotropic agents in the perfused rat heart.
McCormack JG; England PJ
Biochem J; 1983 Aug; 214(2):581-5. PubMed ID: 6193784
[TBL] [Abstract][Full Text] [Related]
45. [Effect of troponin I on the Ca-binding properties of calmodulin and activation of cyclic nucleotide phosphodiesterase by Ca ions].
Men'shikov MIu; Rybin VO; Tkachuk VA
Dokl Akad Nauk SSSR; 1981; 258(5):1250-4. PubMed ID: 6266797
[No Abstract] [Full Text] [Related]
46. The effect of K-252a, a potent microbial inhibitor of protein kinase, on activated cyclic nucleotide phosphodiesterase.
Matsuda Y; Nakanishi S; Nagasawa K; Iwahashi K; Kase H
Biochem J; 1988 Nov; 256(1):75-80. PubMed ID: 2851986
[TBL] [Abstract][Full Text] [Related]
47. [The peptide activator of cyclic nucleotide phosphodiesterases: its effect on muscle contractile activity].
Shchelkovnikov SA; Starshinova LA; Garnovskaia MN; Artem'ev NO; Etingof RN
Biull Eksp Biol Med; 1988 Dec; 106(12):648-50. PubMed ID: 2850035
[TBL] [Abstract][Full Text] [Related]
48. Modulation of calmodulin function and of Ca2+-induced smooth muscle contraction by the calmodulin antagonist, HT-74.
Tanaka T; Umekawa H; Saitoh M; Ishikawa T; Shin T; Ito M; Itoh H; Kawamatsu Y; Sugihara H; Hidaka H
Mol Pharmacol; 1986 Mar; 29(3):264-9. PubMed ID: 3005834
[TBL] [Abstract][Full Text] [Related]
49. Mechanism for ganglioside-mediated modulation of a calmodulin-dependent enzyme. Modulation of calmodulin-dependent cyclic nucleotide phosphodiesterase activity through binding of gangliosides to calmodulin and the enzyme.
Higashi H; Yamagata T
J Biol Chem; 1992 May; 267(14):9839-43. PubMed ID: 1315772
[TBL] [Abstract][Full Text] [Related]
50. Ophiobolin A. A natural product inhibitor of calmodulin.
Leung PC; Taylor WA; Wang JH; Tipton CL
J Biol Chem; 1984 Mar; 259(5):2742-7. PubMed ID: 6321479
[TBL] [Abstract][Full Text] [Related]
51. Protective effects of the calmodulin antagonist bepridil on ischaemia induced in the rat myocardium.
Shikano K; Kusagawa M; Itoh H; Hidaka H
Cardiovasc Res; 1986 May; 20(5):364-8. PubMed ID: 3019548
[TBL] [Abstract][Full Text] [Related]
52. Structures of KS-501 and KS-502, the new inhibitors of Ca2+ and calmodulin-dependent cyclic nucleotide phosphodiesterase.
Yasuzawa T; Saitoh Y; Sano H
J Antibiot (Tokyo); 1990 Apr; 43(4):336-43. PubMed ID: 2161817
[TBL] [Abstract][Full Text] [Related]
53. Glucagon stimulation of ruthenium red-insensitive calcium ion transport in developing rat liver.
Reinhart PH; Bygrave FL
Biochem J; 1981 Feb; 194(2):541-9. PubMed ID: 6171260
[TBL] [Abstract][Full Text] [Related]
54. Ruthenium red inhibits the mitochondrial Ca2+ uptake in intact bovine spermatozoa and increases the cytosolic Ca2+ concentration.
Rigoni F; Deana R
FEBS Lett; 1986 Mar; 198(1):103-8. PubMed ID: 2420637
[TBL] [Abstract][Full Text] [Related]
55. Purification of calmodulin from Chlamydomonas: calmodulin occurs in cell bodies and flagella.
Gitelman SE; Witman GB
J Cell Biol; 1980 Dec; 87(3 Pt 1):764-70. PubMed ID: 6257728
[TBL] [Abstract][Full Text] [Related]
56. [Molecular cardiopharmacology of selective inhibitors of cyclic nucleotide phosphodiesterase isozymes].
Tanaka T; Mukai J; Naka M
Nihon Yakurigaku Zasshi; 1992 Sep; 100(3):249-58. PubMed ID: 1328001
[TBL] [Abstract][Full Text] [Related]
57. Ruthenium red and compound 48/80 inhibit the smooth-muscle plasma-membrane Ca2+ pump via interaction with associated polyphosphoinositides.
Missiaen L; De Smedt H; Droogmans G; Wuytack F; Raeymaekers L; Casteels R
Biochim Biophys Acta; 1990 Apr; 1023(3):449-54. PubMed ID: 1692244
[TBL] [Abstract][Full Text] [Related]
58. On the mechanism of interaction between calmodulin and calmodulin-dependent proteins.
Wang KC; Mutus B; Sharma RK; Lam HY; Wang JH
Can J Biochem Cell Biol; 1983 Aug; 61(8):911-20. PubMed ID: 6313167
[TBL] [Abstract][Full Text] [Related]
59. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages.
Kambayashi T; Jacob CO; Zhou D; Mazurek N; Fong M; Strassmann G
J Immunol; 1995 Nov; 155(10):4909-16. PubMed ID: 7594495
[TBL] [Abstract][Full Text] [Related]
60. Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization.
Rabe KF; Tenor H; Dent G; Schudt C; Liebig S; Magnussen H
Am J Physiol; 1993 May; 264(5 Pt 1):L458-64. PubMed ID: 7684572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
